PIONEERING research into stem cell therapy for stroke patients is to progress to a new stage at Glasgow's Southern General Hospital.
The work is being carried out by experts from Glasgow University in partnership with pharmaceutical company ReNeuron.
A trial is looking at the safety of injecting expanded neural stem cells, in increasing doses, into the brains of 12 patients left disabled by an ischaemic stroke, the most common form of the condition, and monitoring them over a period of two years.
The independent Data Safety Monitoring Board for the clinical trial has recommended the trial advances after a successful study of the method which involved six patients.
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article